• CXI Healthcare Technology Group corrected its acquisition funding disclosure on October 22, 2026, replacing an all-internal-cash funding plan with partial subsidiary borrowing.
• The USD 45.38 million purchase of a 55% stake in AIDT Technologies includes USD 6.6 million borrowed from a subsidiary.
• Internal funds covered the remaining USD 38.78 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CXI Healthcare Technology Group Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261022000428), on October 22, 2026, and is solely responsible for the information contained therein.